Products

CAS: 32986-56-4 Tobramycin Antibiotic Powder

China CAS: 32986-56-4 Tobramycin Antibiotic Powder, Find details about China Tobramycin, 32986-56-4 from CAS: 32986-56-4 Tobramycin Antibiotic Powder

Model NO.
HNB-Tobramycin
Product Name
Tobramycin
CAS
32986-56-4
Molecular Weight
467.514
Molecular Formula
C18h37n5o9
Density
1.5±0.1 g/cm3
Assay
HPLC99%
Sample
10g Available
Factory Supply
Yes
Appearance
White Powder
Usage
Animal Pharmaceuticals
Shelf Life
2 Years Proper Storage
Certificate
GMP/ISO9001
Packing
Carton Box or Drum
Function
Antibiotic
Payment
Tt/Western Union
Trademark
HNB
Transport Package
Carton Box
Specification
HPLC 99%
Origin
China
HS Code
3006920000
Model NO.
HNB-Tobramycin
Product Name
Tobramycin
CAS
32986-56-4
Molecular Weight
467.514
Molecular Formula
C18h37n5o9
Density
1.5±0.1 g/cm3
Assay
HPLC99%
Sample
10g Available
Factory Supply
Yes
Appearance
White Powder
Usage
Animal Pharmaceuticals
Shelf Life
2 Years Proper Storage
Certificate
GMP/ISO9001
Packing
Carton Box or Drum
Function
Antibiotic
Payment
Tt/Western Union
Trademark
HNB
Transport Package
Carton Box
Specification
HPLC 99%
Origin
China
HS Code
3006920000
CAS: 32986-56-4 Tobramycin Antibiotic Powder
Cas:32986-56-4 Tobramycin antibiotic powder
product nameTobramycin
cas number32986-56-4
apperancewhite powder
Density1.5±0.1 g/cm3
MFC18H37N5O9
MW467.514

Tobramycin, alias tobramycin, molecular formula C18H37N5O9, is an aminoglycoside antibiotic. Clinically, it is mainly used to treat neonatal sepsis, sepsis, central nervous system infection (including meningitis), genitourinary system infection, lung infection and other diseases caused by gram-negative bacilli.
CAS: 32986-56-4 Tobramycin Antibiotic Powder
This product is suitable for Pseudomonas aeruginosa, Proteus (indole positive and negative), Escherichia coli, Klebsiella, Enterobacter, Serratia and Staphylococcus (including penicillin G and methicillin resistant strains) Neonatal sepsis, sepsis, central nervous system infections (including meningitis), genitourinary system infections, lung infections, biliary tract infections, abdominal cavity infections (and peritonitis), bone infections, skin and soft tissue infections (including burns) ), acute and chronic otitis media, sinusitis, etc. When used for Pseudomonas aeruginosa meningitis or ventriculitis, the product can be administered by intrathecal injection at the same time; when used for bronchial and lung infections, the product can be inhaled simultaneously as an adjuvant treatment. Tobramycin is ineffective against most group D streptococcal infections. It is effective for conjunctivitis, keratitis and other eye bacterial infections, especially Gram-negative bacterial infections resistant to gentamicin, such as severe Pseudomonas aeruginosa infections.

CAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic Powder
CAS: 32986-56-4 Tobramycin Antibiotic PowderCAS: 32986-56-4 Tobramycin Antibiotic Powder
 

You Might Also Like